Revance Therapeutics Statistics
Total Valuation
PBH has a market cap or net worth of $3.63 billion. The enterprise value is $4.58 billion.
| Market Cap | 3.63B |
| Enterprise Value | 4.58B |
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PBH has 49.23 million shares outstanding. The number of shares has decreased by -0.20% in one year.
| Current Share Class | 49.23M |
| Shares Outstanding | 49.23M |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 106.49% |
| Float | 48.67M |
Valuation Ratios
The trailing PE ratio is 17.18 and the forward PE ratio is 15.43. PBH's PEG ratio is 2.01.
| PE Ratio | 17.18 |
| Forward PE | 15.43 |
| PS Ratio | 3.22 |
| Forward PS | 3.14 |
| PB Ratio | 1.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.92 |
| P/OCF Ratio | 14.43 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.06, with an EV/FCF ratio of 18.81.
| EV / Earnings | 21.32 |
| EV / Sales | 4.02 |
| EV / EBITDA | 12.06 |
| EV / EBIT | 13.10 |
| EV / FCF | 18.81 |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.57.
| Current Ratio | 4.20 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 2.36 |
| Debt / FCF | 4.29 |
| Interest Coverage | 7.33 |
Financial Efficiency
Return on equity (ROE) is 12.30% and return on invested capital (ROIC) is 7.69%.
| Return on Equity (ROE) | 12.30% |
| Return on Assets (ROA) | 6.50% |
| Return on Invested Capital (ROIC) | 7.69% |
| Return on Capital Employed (ROCE) | 10.60% |
| Revenue Per Employee | $1.90M |
| Profits Per Employee | $357,675 |
| Employee Count | 600 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.45 |
Taxes
In the past 12 months, PBH has paid $69.58 million in taxes.
| Income Tax | 69.58M |
| Effective Tax Rate | 24.49% |
Stock Price Statistics
The stock price has increased by +4.11% in the last 52 weeks. The beta is 0.43, so PBH's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +4.11% |
| 50-Day Moving Average | 80.76 |
| 200-Day Moving Average | 81.10 |
| Relative Strength Index (RSI) | 28.50 |
| Average Volume (20 Days) | 427,791 |
Short Selling Information
The latest short interest is 1.51 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 1.51M |
| Short Previous Month | 1.66M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 3.11% |
| Short Ratio (days to cover) | 3.44 |
Income Statement
In the last 12 months, PBH had revenue of $1.14 billion and earned $214.61 million in profits. Earnings per share was $4.29.
| Revenue | 1.14B |
| Gross Profit | 643.35M |
| Operating Income | 349.24M |
| Pretax Income | 265.73M |
| Net Income | 214.61M |
| EBITDA | 379.41M |
| EBIT | 349.24M |
| Earnings Per Share (EPS) | $4.29 |
Balance Sheet
The company has $97.88 million in cash and $1.04 billion in debt, giving a net cash position of -$946.37 million or -$19.22 per share.
| Cash & Cash Equivalents | 97.88M |
| Total Debt | 1.04B |
| Net Cash | -946.37M |
| Net Cash Per Share | -$19.22 |
| Equity (Book Value) | 1.83B |
| Book Value Per Share | 37.06 |
| Working Capital | 341.71M |
Cash Flow
In the last 12 months, operating cash flow was $251.52 million and capital expenditures -$8.22 million, giving a free cash flow of $243.29 million.
| Operating Cash Flow | 251.52M |
| Capital Expenditures | -8.22M |
| Free Cash Flow | 243.29M |
| FCF Per Share | $4.94 |
Margins
Gross margin is 56.54%, with operating and profit margins of 30.70% and 18.86%.
| Gross Margin | 56.54% |
| Operating Margin | 30.70% |
| Pretax Margin | 24.98% |
| Profit Margin | 18.86% |
| EBITDA Margin | 33.35% |
| EBIT Margin | 30.70% |
| FCF Margin | 21.38% |
Dividends & Yields
PBH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.20% |
| Shareholder Yield | 0.20% |
| Earnings Yield | 5.91% |
| FCF Yield | 6.70% |
Analyst Forecast
The average price target for PBH is $94.00, which is 27.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $94.00 |
| Price Target Difference | 27.51% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 2.08% |
| EPS Growth Forecast (5Y) | 5.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PBH has an Altman Z-Score of 2.85 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 8 |